Why the study?
Does NT-proBNP testing at presentation predict 1-year mortality in patients with dyspnea treated in the emergency department?
Does NT-proBNP testing at presentation predict 1-year mortality in patients with dyspnea treated in the emergency department?
NT-proBNP testing at presentation provides strong prognostic value for 1-year mortality in dyspneic patients in the emergency department.
May aid ED risk stratification in dyspnea; leaves open effects on management or outcomes.
In addition to assisting in emergency department diagnosis and triage, NT-proBNP concentrations at presentation are strongly predictive of 1-year mortality in dyspneic patients.
No takes yet. Share an insight, caveat, or question.
Januzzi et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: